Biomedicines,
Год журнала:
2024,
Номер
12(4), С. 765 - 765
Опубликована: Март 29, 2024
Diabetic
cardiomyopathy
(DCM)
is
the
development
of
myocardial
dysfunction
in
patients
with
diabetes
despite
absence
comorbidities
such
as
hypertension,
atherosclerosis
or
valvular
defect.
The
cardiovascular
complications
poorly
controlled
are
very
well
illustrated
by
U.K.
Prospective
Diabetes
Study
(UKPDS),
which
showed
a
clear
association
between
increasing
levels
glycated
hemoglobin
and
heart
failure
(HF).
incidence
HF
projected
to
increase
significantly,
why
its
proper
diagnosis
treatment
so
important.
Providing
appropriate
therapy
focusing
on
antidiabetic
hypolipemic
consideration
pharmacotherapy
for
reduces
risk
CMD
complications.
Health-promoting
changes
made
low-carbohydrate
diet,
regular
exercise
weight
reduction
also
appear
be
important
achieving
outcomes.
New
hope
therapies
DCM
offered
novel
methods
using
stem
cells
miRNA,
which,
however,
require
more
thorough
research
confirm
their
efficacy.
Cardiovascular Diabetology,
Год журнала:
2024,
Номер
23(1)
Опубликована: Янв. 6, 2024
Abstract
Background
In
the
American
population,
relationship
between
triglyceride-glucose
(TyG)
index
and
TYG
combined
with
indicators
of
obesity
cardiovascular
disease
(CVD)
its
mortality
has
been
less
well
studied.
Methods
This
cross-sectional
study
included
11,937
adults
from
National
Health
Nutrition
Examination
Survey
(NHANES)
2003–2018.
Cox
proportional
hazards
model,
binary
logistic
regression
analyses,
restricted
cubic
spline
(RCS),
receiver
operating
characteristic
(ROC)
were
used
to
analyze
TyG
obesity-related
CVD
mortality.
Mediation
analysis
explored
mediating
role
glycated
hemoglobin
insulin
in
above
relationships.
Results
this
study,
except
for
no
significant
association
mortality,
TyG,
TyG-WC,
TyG-WHtR,
TyG-BMI
significantly
positively
associated
TyG-WHtR
is
strongest
predictor
(HR
1.66,
95%
CI
1.21–2.29).
The
correlated
better
risk
coronary
heart
(OR
2.52,
1.66–3.83).
TyG-WC
best
total
2.37,
1.77–3.17),
congestive
failure
2.14,
1.31–3.51),
angina
pectoris
2.38,
1.43–3.97).
myocardial
infarction
2.24,
1.45–3.44).
RCS
analyses
showed
that
most
relationships
linear
(P-overall
<
0.0001,
P-nonlinear
>
0.05).
Otherwise,
ROC
curves
had
more
robust
diagnostic
efficacy
than
TyG.
mediation
mediated
all
insulin-mediated
partial
Conclusions
TyG-WtHR
enhance
prediction,
correlation
some
over
current
hottest
are
expected
become
effective
metrics
identifying
populations
at
early
improve
stratification.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Март 1, 2024
Abstract
Peroxisome
proliferator-activated
receptor
gamma
coactivator-1
(PGC-1)
family
(PGC-1s),
consisting
of
three
members
encompassing
PGC-1α,
PGC-1β,
and
PGC-1-related
coactivator
(PRC),
was
discovered
more
than
a
quarter-century
ago.
PGC-1s
are
essential
coordinators
many
vital
cellular
events,
including
mitochondrial
functions,
oxidative
stress,
endoplasmic
reticulum
homeostasis,
inflammation.
Accumulating
evidence
has
shown
that
implicated
in
diseases,
such
as
cancers,
cardiac
diseases
cardiovascular
neurological
disorders,
kidney
motor
system
metabolic
disorders.
Examining
the
upstream
modulators
co-activated
partners
identifying
critical
biological
events
modulated
by
downstream
effectors
contribute
to
presentation
elaborate
network
PGC-1s.
Furthermore,
discussing
correlation
between
well
summarizing
therapy
targeting
helps
make
individualized
precise
intervention
methods.
In
this
review,
we
summarize
basic
knowledge
regarding
molecular
regulatory
network,
discuss
physio-pathological
roles
human
review
application
PGC-1s,
diagnostic
prognostic
value
several
therapies
pre-clinical
studies,
suggest
directions
for
future
investigations.
This
presents
immense
potential
treatment
hopefully
facilitates
promotion
new
therapeutic
targets.
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
13
Опубликована: Янв. 16, 2023
Chronic
kidney
disease
(CKD)
causes
considerable
morbidity,
mortality,
and
health
expenditures
worldwide.
Obesity
is
a
significant
risk
factor
for
CKD
development,
partially
explained
by
the
high
prevalence
of
diabetes
mellitus
hypertension
in
obese
patients.
However,
adipocytes
also
possess
potent
endocrine
functions,
secreting
myriad
cytokines
adipokines
that
contribute
to
insulin
resistance
induce
chronic
low-grade
inflammatory
state
thereby
damaging
kidney.
development
itself
associated
with
various
metabolic
alterations
exacerbate
adipose
tissue
dysfunction
resistance.
This
adipose-renal
axis
major
focus
current
research,
given
rising
incidence
obesity.
Cellular
senescence
biologic
hallmark
aging,
age
another
obesity
CKD.
An
elevated
senescent
cell
burden
predicts
renal
animal
models,
senotherapies
may
alleviate
these
phenotypes.
In
this
review,
we
discuss
direct
mechanisms
which
contributes
emphasizing
potential
clinical
importance
such
pathways
augmenting
care
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 1211 - 1211
Опубликована: Янв. 19, 2024
This
comprehensive
review
explores
the
critical
role
of
fatty
acid
(FA)
metabolism
in
cardiac
diseases,
particularly
heart
failure
(HF),
and
implications
for
therapeutic
strategies.
The
heart’s
reliance
on
ATP,
primarily
sourced
from
mitochondrial
oxidative
metabolism,
underscores
significance
metabolic
flexibility,
with
oxidation
(FAO)
being
a
dominant
source.
In
HF,
shifts
occur
an
altered
FA
uptake
FAO,
impacting
function
contributing
to
disease
progression.
Conditions
like
obesity
diabetes
also
lead
disturbances,
resulting
cardiomyopathy
marked
by
over-reliance
dysfunction,
lipotoxicity.
Therapeutic
approaches
targeting
diseases
have
evolved,
focusing
inhibiting
or
stimulating
FAO
optimize
energetics.
Strategies
include
using
CPT1A
inhibitors,
PPARα
agonists,
enhancing
biogenesis
function.
However,
effectiveness
varies,
reflecting
complexity
remodeling
HF.
Hence,
treatment
strategies
should
be
individualized,
considering
that
energy
is
intricate
tightly
regulated.
aim
overall
function,
recognizing
pivotal
FAs
need
further
research
develop
effective
therapies,
promising
new
improve
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Янв. 12, 2025
Physical
exercise
is
a
cornerstone
for
preventing
diet-induced
obesity,
while
it
unclear
whether
physical
could
offset
high-fat,
high-calories
diet
(HFCD)-induced
cardiac
dysfunction.
Here,
mice
were
fed
with
HFCD
and
simultaneously
subjected
to
exercise.
As
expected,
prevented
HFCD-induced
whole-body
fat
deposition.
However,
exacerbated
damage.
Further
metabolomic
analysis
results
showed
that
induced
circulating
lipid
redistribution,
leading
excessive
uptake
lipotoxicity.
Our
study
provides
valuable
insights
into
the
effects
of
in
HFCD,
suggesting
counteracting
negative
effect
by
simultaneous
might
be
detrimental.
Moreover,
inappropriate
may
damage
certain
organs
even
though
leads
weight
loss
overall
metabolic
benefits.
Of
note,
current
findings
are
based
on
animal
experiments,
generalizability
these
beyond
this
specific
mouse
strain
remains
further
explored.
While
benefits
well
known,
less
clear
can
prevent
obesity.
authors
show
gain
mice,
surprisingly
worsened
heart
due
Medicinal Research Reviews,
Год журнала:
2022,
Номер
43(1), С. 5 - 30
Опубликована: Авг. 17, 2022
Abstract
The
endoplasmic
reticulum
(ER)
governs
the
proper
folding
of
polypeptides
and
proteins
through
various
chaperones
enzymes
residing
within
ER
organelle.
Perturbation
in
process
ensues
when
overwhelmed
protein
exceeds
handling
capacity,
leading
to
accumulation
misfolded/unfolded
lumen—a
state
being
referred
as
stress.
In
turn,
stress
induces
a
gamut
signaling
cascades,
termed
“unfolded
response”
(UPR)
that
reinstates
homeostasis
panel
gene
expression
modulation.
This
type
UPR
is
usually
deemed
“adaptive
UPR.”
However,
persistent
or
unresolved
hyperactivates
response,
which
ultimately,
triggers
cell
death
inflammatory
pathways,
“maladaptive/terminal
A
plethora
evidence
indicates
crosstalks
between
(maladaptive
UPR)
inflammation
precipitate
obesity
pathogenesis.
this
regard,
acquisition
mechanisms
linking
might
unveil
potential
remedies
tackle
pathological
condition.
Herein,
we
aim
elucidate
key
stress‐induced
context
summarize
therapeutic
strategies
management
maneuvering
stress‐associated
inflammation.
Nutrients,
Год журнала:
2022,
Номер
14(2), С. 251 - 251
Опубликована: Янв. 7, 2022
Intermittent
fasting
(IF)
plays
an
essential
role
in
improving
lipid
metabolism
disorders
caused
by
metabolic
cardiomyopathy.
Growing
evidence
revealed
that
N6-methyladenosine
(m6A)
RNA
methylation
is
related
to
obesity
and
metabolic.
Our
study
aimed
assess
the
beneficial
effects
of
IF
on
deposition,
apoptosis,
m6A
high-fat
diet
(HFD)-induced
Male
C57BL/6J
mice
were
fed
a
normal
(ND)
or
HFD
ad
libitum
for
13
weeks,
after
which
time
subgroup
subjected
24
h
other
day
8
weeks.
We
found
intervention
significantly
improved
cardiac
functional
structural
impairment
serum
disorder
induced
HFD.
Furthermore,
decreased
mRNA
levels
fatty
acid
uptake
genes
FABP1,
FATP1,
CD36
synthesis
SREBF1,
FAS,
ACCα
increased
catabolism
ATGL,
HSL,
LAL,
LPL
tissueof
HFD-induced
obese
mice.
TUNEL-positive
cells,
Bax/Bcl-2
ratio,
Cleaved
Caspase-3
protein
expression
hearts
was
down-regulated
intervention.
In
addition,
METTL3
FTO
conclusion,
our
findings
demonstrate
attenuated
deposition
as
well
cardiomyopathy,
mechanism
associated
with
levels.
Cells,
Год журнала:
2022,
Номер
11(7), С. 1101 - 1101
Опубликована: Март 24, 2022
Cardiometabolic
diseases
(CMDs)
are
currently
the
leading
cause
of
death
and
disability
worldwide,
their
underlying
regulatory
mechanisms
remain
largely
unknown.
N6-methyladenosine
(m6A)
methylation,
most
common
abundant
epigenetic
modification
eukaryotic
mRNA,
is
regulated
by
m6A
methyltransferase,
demethylase,
binding
protein,
which
affect
transcription,
cleavage,
translation,
degradation
target
mRNA.
methylation
plays
a
vital
role
in
physiological
pathological
processes
CMDs.
In
this
review,
we
summarize
played
CMDs,
including
obesity,
hypertension,
pulmonary
ischemic
heart
disease,
myocardial
hypertrophy,
failure,
atherosclerosis.
We
also
describe
that
potentially
involve
participation
such
as
those
driving
calcium
homeostasis,
circadian
rhythm,
lipid
metabolism,
autophagy,
macrophage
response,
inflammation.
its
regulators
expected
to
be
targets
for
treatment